Urine High-Sensitivity Troponin I Predict Incident Cardiovascular Events in Patients with Diabetes Mellitus
Ju-Yi Chen1, Shuenn-Yuh Lee2, Yi-Heng Li1
1Division of Cardiology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.
Insights
Urinary high-sensitivity troponin I (hs-TnI) can predict cardiovascular events in diabetes mellitus patients. This non-invasive biomarker offers a promising tool for early risk assessment in diabetic individuals.
Area of Science:
- Cardiology
- Diabetology
- Biomarker Research
Background:
- Cardiovascular (CV) events significantly worsen outcomes for patients with diabetes mellitus (DM).
- Serum high-sensitivity troponin I (hs-TnI) is established for acute coronary syndrome but its utility in urine for DM patients is under-researched.
- Predicting incident CV events in DM requires accessible and reliable biomarkers.
Purpose of the Study:
- To investigate the accuracy of urine hs-TnI as a predictor of incident CV events in patients with DM.
- To establish the diagnostic and prognostic value of urinary hs-TnI in a diabetic cohort.
- To determine an optimal cutoff value for urine hs-TnI for CV event prediction.
Main Methods:
- Prospective study involving 378 patients with DM.
- Measurement of fresh urine hs-TnI levels.
- Follow-up for incident CV events over 3 months using medical records.
Main Results:
- Significantly higher urine hs-TnI levels were observed in patients who experienced subsequent CV events.
- Multivariate logistic regression identified urine hs-TnI > 4.10 pg/mL as an independent predictor of incident CV events.
- ROC-AUC analysis indicated an optimal cutoff of 1.55 pg/mL for urine hs-TnI, with an area of 0.611 (p=0.027).
Conclusions:
- Urinary hs-TnI is a potential non-invasive biomarker for predicting incident CV events in patients with DM.
- A single urine hs-TnI measurement may be a convenient and acceptable method for CV risk assessment in this population.
- Further research can validate urine hs-TnI for routine clinical use in managing diabetic cardiovascular risk.
Abstract:
In patients with diabetes mellitus (DM), incident cardiovascular (CV) events are associated with poor long-term outcomes. Serum high-sensitivity troponin I (hs-TnI) is widely used to diagnose and predict outcomes in patients with acute coronary syndrome, however, few studies have investigated the accuracy of urine hs-TnI as a predictor for incident CV events in patients with DM. The enrolled participants included patients with DM. Fresh urine hs-TnI levels were measured. Medical records of enrolled patients were used to determine the number of incident CV events prospectively for 3 months. The study cohort comprised 378 participants. We observed significantly higher levels of urine hs-TnI in those with than without subsequent incident CV events. The multivariate logistic regression analysis using different models consistently showed that urine hs-TnI > 4.10 pg/mL was an independent factor predictive of incident CV events. The ROC-AUC analysis revealed that the optimal cutoff value for urine hs-TnI for predicting incident CV events was 1.55 pg/mL and the area was 0.611 (p = 0.027). A single measurement of urinary hs-TnI, collected easily and non-invasively, may be an acceptable biomarker for predicting subsequent incident CV events in patients with DM.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Urine Studies I: Urinalysis
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Diabetes: Symptoms, Diagnosis, and Complications
Acute Coronary Syndrome III: Diagnostic Studies
Acute Kidney Injury IV: Diagnostic Studies and Prevention


